Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310505
Status:
COMPLETED
Last Update Posted:
2008-09-12
First Post:
2006-04-03
Brief Title:
Amphotericin B Treatment in Visceral Leishmaniasis
Sponsor:
Banaras Hindu University
Organization:
Banaras Hindu University
Study Overview
Official Title:
Randomised Double Blind Dose Ranging Study of Amphotericin B in Visceral Leishmaniasis
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 075 mgkg or 10 mgkg for 15 doses In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested
Detailed Description:
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 075 mgkg or 10 mgkg for 15 doses In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None